Metformin Hydrochloride Extended Release 1000 mg tablets | Steris Pharma Pvt Ltd.
Extended Release Metformin Hydrochloride 1000 mg tablets are widely prescribed for managing type 2 diabetes mellitus. Metformin Hydrochloride 1000 mg tablets Manufactured by Steris Pharma Pvt Ltd, these tablets help regulate blood sugar levels efficiently. This article provides a comprehensive guide to Extended Release Metformin Hydrochloride, its formulations, benefits, and combination therapies.
What is Extended Release Metformin Hydrochloride
Extended Release (ER) Metformin Hydrochloride is a formulation designed to provide gradual drug release, ensuring prolonged therapeutic effects with minimal side effects. It helps in:
Improving insulin sensitivity
Reducing hepatic glucose production
Enhancing glucose uptake in muscles
Unlike immediate-release formulations, Metformin Hydrochloride Extended Release is taken once daily, improving patient compliance and reducing gastrointestinal side effects.
Metformin Hydrochloride Tablets IP
The Metformin Hydrochloride Tablets IP are manufactured according to Indian Pharmacopoeia (IP) standards, ensuring high quality and efficacy. These tablets are commonly prescribed as monotherapy or in combination with other antidiabetic agents to control blood sugar levels effectively.
Benefits of Metformin Hydrochloride Tablets IP
Helps control high blood sugar levels
Supports weight management in diabetic patients
Reduces the risk of cardiovascular complications
Minimizes the likelihood of hypoglycemia when used alone
Metformin Hydrochloride Prolonged Release 1000 mg
Metformin Hydrochloride Prolonged Release 1000 mg is an advanced formulation that provides a steady release of metformin over an extended period. This enhances patient tolerance and effectiveness in managing type 2 diabetes.
Why Choose Prolonged Release Formulations?
Fewer gastrointestinal side effects
Stable blood glucose levels throughout the day
Improved patient adherence due to reduced dosing frequency
Metformin Hydrochloride Prolonged Release Tablets
These tablets ensure a controlled and sustained release of metformin into the bloodstream, which is crucial for preventing spikes and dips in glucose levels. Metformin Hydrochloride Prolonged Release Tablets are particularly beneficial for individuals who experience stomach upset with immediate-release formulations.
Gliclazide and Metformin Hydrochloride Tablets
Gliclazide and Metformin Hydrochloride Tablets combine two potent antidiabetic medications:
Metformin Hydrochloride: Reduces hepatic glucose production
Gliclazide: A sulfonylurea that stimulates insulin release from the pancreas
This combination is effective in improving glycemic control, particularly in patients who do not respond well to metformin alone.
Uses of Gliclazide and Metformin Hydrochloride Tablets
Enhances insulin secretion
Controls fasting and postprandial glucose levels
Reduces the risk of diabetic complications
Glimepiride and Metformin Hydrochloride Tablets
Glimepiride and Metformin Hydrochloride Tablets are another effective combination therapy used in the treatment of type 2 diabetes.
Benefits of Glimepiride and Metformin Hydrochloride Tablets
Glimepiride stimulates insulin release and increases peripheral glucose utilization
Metformin Hydrochloride lowers hepatic glucose output
Together, they provide superior glycemic control compared to monotherapy
Vildagliptin and Metformin Hydrochloride Tablets Uses
Vildagliptin and Metformin Hydrochloride Tablets are prescribed to improve glycemic control in patients with type 2 diabetes. Vildagliptin is a DPP-4 inhibitor that enhances insulin secretion and reduces glucagon levels, complementing Metformin’s effects.
Key Uses of Vildagliptin and Metformin Hydrochloride Tablets
Enhances glucose-dependent insulin secretion
Reduces excessive glucagon levels in fasting and postprandial states
Provides better blood sugar control compared to monotherapy
Vildagliptin and Metformin Hydrochloride Tablets
These combination tablets are widely prescribed for type 2 diabetes management due to their ability to regulate both insulin secretion and glucose production efficiently.
Advantages of Vildagliptin and Metformin Hydrochloride Combination
Dual mechanism: Targets multiple pathways for improved glycemic control
Lower risk of hypoglycemia: Vildagliptin works in a glucose-dependent manner
Improved tolerance: Reduces gastrointestinal side effects associated with metformin alone.
Why Choose Metformin Hydrochloride Tablets from Steris Pharma Pvt Ltd?
Steris Pharma Pvt Ltd is known for manufacturing high-quality Metformin Hydrochloride Tablets IP and its combination therapies. Their formulations are:
Clinically tested for safety and efficacy
Manufactured under stringent quality control standards
Designed for optimal absorption and patient compliance
Why Choose Steris For Metformin Hydrochloride Extended Release 1000 mg Tablet.
Metformin Hydrochloride Extended Release 1000 mg Tablets are a cornerstone in the management of type 2 diabetes. The prolonged-release formulations, as well as combination therapies with Gliclazide, Glimepiride, and Vildagliptin, offer enhanced glycemic control while minimizing side effects. Steris Pharma Pvt Ltd ensures the highest quality standards in its production, making these formulations a trusted choice for healthcare professionals worldwide.
